Allovir Inc

General ticker "ALVR" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $76.2M (TTM average)

Allovir Inc does not follow the US Stock Market performance with the rate: -24.9%.

Estimated limits based on current volatility of 2.9%: low 9.45$, high 10.02$

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [5.54$, 20.04$]
  • 2025-12-31 to 2026-12-31 estimated range: [6.04$, 19.86$]

Financial Metrics affecting the ALVR estimates:

  • Negative: Non-GAAP EPS, $ of -6.21 <= 0.04
  • Negative: negative Net income
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -0.12 <= 1.79
  • Negative: Industry operating cash flow per share per price (median), % of -20.99 <= 2.90
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term ALVR quotes

Long-term ALVR plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $171.20MM $199.90MM $65.44MM
Operating Income $-171.20MM $-199.90MM $-65.44MM
Non-Operating Income $2.23MM $9.36MM $6.67MM
R&D Expense $118.87MM $133.07MM $12.34MM
Income(Loss) $-168.97MM $-190.54MM $-58.77MM
Taxes $-0.27MM $-0.13MM $0.00MM
Profit(Loss)* $-168.71MM $-190.42MM $-58.77MM
Stockholders Equity $224.52MM $145.78MM $113.31MM
Inventory $0.16MM $0.00MM $0.00MM
Assets $277.08MM $190.80MM $118.55MM
Operating Cash Flow $-142.05MM $-124.45MM $-67.70MM
Capital expenditure $0.10MM $0.00MM $0.00MM
Investing Cash Flow $-80.48MM $37.98MM $95.00MM
Financing Cash Flow $126.96MM $70.50MM $0.02MM
Earnings Per Share** $-2.20 $-1.83 $-0.01

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.